It’s been over a year since the announcement of the Single National Formulary (SNF). No question – this is a really big one for pharma, and at my new company, Life Science Access Academy, we’re getting lots of queries about it.
There have been some announcements, directions of travel and timelines in the midst, and in some therapy areas the shape is becoming clearer. But at the moment this feels like a slightly scary area with many questions unanswered. Article idea: list them, so we can all feel apprehensive about the same things, together!
The basic premise of the SNF announced in the 10-Year Health Plan last summer had many backers in industry. Okay, many sceptics too – but the broad idea of replacing England’s multitude of bureaucratic, duplicative and postcode-variable local market access systems seemed a good one. It had been challenging and annoying much of pharma for years.
Check out the rest of the feature here
